and Mission We are a revenue stage medical technology and healthcare services company that features a comprehensive suite of proprietary oral appliances and therapeutic treatments. Our products non-surgically treat certain maxillofacial and developmental abnormalities of the mouth and jaws that are closely associated with breathing and sleep disorders such as mild to severe obstructive sleep ap…
$0.90
$0.13 (-13.02%)
Price from 41 days ago
The business is unprofitable at the operating level (-114.05% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 16.0%, still solid. Margins contracted 39.7pp, which offsets some of the top-line progress.
Negative free cash flow of -$18M. The business is consuming cash, not generating it. Operating margin contracted 39.7pp YoY, cost discipline may be slipping.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$20M
▲ +16.0% YoY
Net Income (TTM)
-$25M
▼ -90.1% YoY
Op. Margin
-115.45%
▼ -39.7pp YoY
ROIC
-81.54%
▲ +26.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$20M
▼ -32.8% YoY
Op. Cash Flow (TTM)
-$17M
▼ -20.3% YoY
Net Debt
$17M
Cash & Equiv.
$2M
5Y CAGR: +5.9%
Continue Research